419 related articles for article (PubMed ID: 21507567)
1. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.
Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL
Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567
[TBL] [Abstract][Full Text] [Related]
2. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
Mastaglia FL; Needham M; Scott A; James I; Zilko P; Day T; Kiers L; Corbett A; Witt CS; Allcock R; Laing N; Garlepp M; Christiansen FT
Neuromuscul Disord; 2009 Nov; 19(11):763-5. PubMed ID: 19720533
[TBL] [Abstract][Full Text] [Related]
3. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
4. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N
Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
[TBL] [Abstract][Full Text] [Related]
5. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
Chung SH; Bent EI; Weiss MD; Gardner GC
Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496
[TBL] [Abstract][Full Text] [Related]
6. Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain.
Lindvall B; Bengtsson A; Ernerudh J; Eriksson P
J Rheumatol; 2002 Apr; 29(4):717-25. PubMed ID: 11950012
[TBL] [Abstract][Full Text] [Related]
7. HL-A antigen in Sjögren's syndrome.
Nahir AM; Scharf Y; Gidoni O; Koren L; Zonis S; Barzilai A
Ann Ophthalmol; 1980 Sep; 12(9):1084-6. PubMed ID: 6985419
[TBL] [Abstract][Full Text] [Related]
8. Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Limaye VS; Cash K; Smith C; Koszyca B; Patel S; Greenberg SA; Hissaria P
Muscle Nerve; 2020 May; 61(5):570-574. PubMed ID: 32035011
[TBL] [Abstract][Full Text] [Related]
9. [Primary Sjögren's syndrome and glomerulonephritis].
Tholl U; Hartung K; Helmchen U; Anlauf M
Dtsch Med Wochenschr; 1998 Dec; 123(51-52):1541-6. PubMed ID: 9893680
[TBL] [Abstract][Full Text] [Related]
10. The immunogenetic relationship between anti-Ro(SS-A)/La(SS-B) antibody positive Sjögren's/lupus erythematosus overlap syndrome and the neonatal lupus syndrome.
Alexander EL; McNicholl J; Watson RM; Bias W; Reichlin M; Provost TT
J Invest Dermatol; 1989 Dec; 93(6):751-6. PubMed ID: 2584740
[TBL] [Abstract][Full Text] [Related]
11. DRB1*15 and DRB1*03 extended haplotype interaction in primary Sjögren's syndrome genetic susceptibility.
Jean S; Quelvennec E; Alizadeh M; Guggenbuhl P; Birebent B; Perdriger A; Grosbois B; Pawlotsky PY; Semana G
Clin Exp Rheumatol; 1998; 16(6):725-8. PubMed ID: 9844767
[TBL] [Abstract][Full Text] [Related]
12. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.
Needham M; James I; Corbett A; Day T; Christiansen F; Phillips B; Mastaglia FL
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1056-60. PubMed ID: 18258695
[TBL] [Abstract][Full Text] [Related]
13. HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members.
Mann DL; Moutsopoulos HM
Ann Rheum Dis; 1983 Oct; 42(5):533-6. PubMed ID: 6605120
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
[TBL] [Abstract][Full Text] [Related]
15. [Primary Sjögren syndrome and inclusion body myositis].
Monteiro P; Coutinho M; Salvador MJ; Malcata A
Acta Reumatol Port; 2009; 34(2A):261-5. PubMed ID: 19474780
[TBL] [Abstract][Full Text] [Related]
16. [Association of systemic lupus erythematosus and Sjögren's syndrome].
Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.
Needham M; Corbett A; Day T; Christiansen F; Fabian V; Mastaglia FL
J Clin Neurosci; 2008 Dec; 15(12):1350-3. PubMed ID: 18815046
[TBL] [Abstract][Full Text] [Related]
18. Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
Mattey DL; González-Gay MA; Hajeer AH; Dababneh A; Thomson W; García-Porrúa C; Ollier WE
J Rheumatol; 2000 Nov; 27(11):2611-6. PubMed ID: 11093441
[TBL] [Abstract][Full Text] [Related]
19. [Inclusion body myositis associated with chronic thyroiditis, Sjögren's syndrome and autoimmune cholangitis].
Hama K; Miwa H; Nishino I; Nonaka I; Kondo T
No To Shinkei; 2004 Jun; 56(6):503-7. PubMed ID: 15328839
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between HLA D region gene and primary Sjögren's syndrome].
Fei H; Scharf S; Erlich H; Peebles C; Tan E; Fox R
Zhonghua Yi Xue Za Zhi; 1991 Oct; 71(10):555-9, 38. PubMed ID: 1686576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
